Why is Novo Nordisk’s stock up? Here’s what to know about its weight loss drug Wegovy’s heart disease trials
Published
The European drugmaker’s stock is rallying Tuesday after a study showed its popular weight loss pill Wegovy could lower risks of heart attack and stroke. On Tuesday, European company Novo Nordisk’s shares hit record highs. While the shares have surged over 150% in the past two years, they were up…
#novonordisks #readfullstory